$GSLR
GeoSolar Technologies, Inc.

2024 Q2 Form 10-Q Financial Statement

#000168316824003370 Filed on May 14, 2024

View on sec.gov

Income Statement

Concept 2024 Q2 2024 Q1
Revenue $12.32K $0.00
YoY Change
Cost Of Revenue $10.29K
YoY Change
Gross Profit $2.022K
YoY Change
Gross Profit Margin 16.42%
Selling, General & Admin $362.9K $376.4K
YoY Change -57.05%
% of Gross Profit 17948.57%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses $362.9K $376.4K
YoY Change -57.05% -51.36%
Operating Profit -$360.9K
YoY Change -57.29%
Interest Expense -$53.42K $53.55K
YoY Change -253.46% 58.08%
% of Operating Profit
Other Income/Expense, Net -$53.42K -$53.55K
YoY Change 53.46% 58.08%
Pretax Income -$414.3K -$429.9K
YoY Change -52.91%
Income Tax
% Of Pretax Income
Net Earnings -$414.3K -$429.9K
YoY Change -52.91% -46.77%
Net Earnings / Revenue -3364.34%
Basic Earnings Per Share -$0.01 -$0.01
Diluted Earnings Per Share -$0.01 -$0.01
COMMON SHARES
Basic Shares Outstanding 65.55M shares 65.35M shares
Diluted Shares Outstanding 65.55M shares 65.07M shares

Balance Sheet

Concept 2024 Q2 2024 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $2.370K $22.79K
YoY Change -74.6%
Cash & Equivalents $2.371K $22.79K
Short-Term Investments
Other Short-Term Assets $42.73K $8.350K
YoY Change 192.87%
Inventory
Prepaid Expenses $42.73K $8.352K
Receivables
Other Receivables
Total Short-Term Assets $45.10K $31.14K
YoY Change 88.6% 38.53%
LONG-TERM ASSETS
Property, Plant & Equipment $464.7K $464.7K
YoY Change 0.0%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $495.0K $495.0K
YoY Change
Total Long-Term Assets $959.7K $959.7K
YoY Change 106.51% 106.51%
TOTAL ASSETS
Total Short-Term Assets $45.10K $31.14K
Total Long-Term Assets $959.7K $959.7K
Total Assets $1.005M $990.9K
YoY Change 105.63% 103.37%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $304.3K $300.7K
YoY Change 17.6% 45.37%
Accrued Expenses $1.021M $968.3K
YoY Change -0.62% 3.11%
Deferred Revenue
YoY Change
Short-Term Debt $1.996M $1.986M
YoY Change 90.7%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $4.433M $4.141M
YoY Change 44.66% 46.39%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00 $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $4.433M $4.141M
Total Long-Term Liabilities $0.00 $0.00
Total Liabilities $4.433M $4.141M
YoY Change 44.66% 46.39%
SHAREHOLDERS EQUITY
Retained Earnings -$13.79M -$13.38M
YoY Change 16.38% 21.93%
Common Stock $6.556K $6.556K
YoY Change 5.55% 6.07%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$3.428M -$3.151M
YoY Change
Total Liabilities & Shareholders Equity $1.005M $990.9K
YoY Change 105.63% 103.37%

Cashflow Statement

Concept 2024 Q2 2024 Q1
OPERATING ACTIVITIES
Net Income -$414.3K -$429.9K
YoY Change -52.91% -46.77%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities -$18.88K -$58.91K
YoY Change -75.76% 100.82%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -1.540K $76.43K
YoY Change -102.11% 119.64%
NET CHANGE
Cash From Operating Activities -18.88K -$58.91K
Cash From Investing Activities
Cash From Financing Activities -1.540K $76.43K
Net Change In Cash -20.42K $17.52K
YoY Change 308.4% 220.65%
FREE CASH FLOW
Cash From Operating Activities -$18.88K -$58.91K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2024Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2023Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2024Q1 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
23584 usd
CY2023Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
0 usd
CY2024Q1 us-gaap Other Notes Payable Current
OtherNotesPayableCurrent
1537 usd
CY2023Q4 us-gaap Other Notes Payable Current
OtherNotesPayableCurrent
5106 usd
CY2024Q1 GSLR Senior Convertible Notes Payable Related Party
SeniorConvertibleNotesPayableRelatedParty
749795 usd
CY2023Q4 GSLR Senior Convertible Notes Payable Related Party
SeniorConvertibleNotesPayableRelatedParty
749795 usd
CY2024Q1 us-gaap Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
1235000 usd
CY2023Q4 us-gaap Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
1235000 usd
CY2024Q1 us-gaap Liabilities Current
LiabilitiesCurrent
4141415 usd
CY2023Q4 us-gaap Liabilities Current
LiabilitiesCurrent
3981825 usd
CY2024Q1 us-gaap Liabilities
Liabilities
4141415 usd
CY2023Q4 us-gaap Liabilities
Liabilities
3981825 usd
CY2024Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2023Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2024Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
20000000 shares
CY2023Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
20000000 shares
CY2024Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2024Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2023Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2023Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2024Q1 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2023Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000 shares
CY2024Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
65552040 shares
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
64252040 shares
CY2024Q1 us-gaap Common Stock Value
CommonStockValue
6556 usd
CY2023Q4 us-gaap Common Stock Value
CommonStockValue
6426 usd
CY2024Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
10221896 usd
CY2023Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
9937436 usd
CY2024Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-13378989 usd
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-12949047 usd
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
-3150537 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
-3005185 usd
CY2024Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
990878 usd
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
976640 usd
CY2024Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
376394 usd
CY2023Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
773850 usd
CY2024Q1 us-gaap Operating Expenses
OperatingExpenses
376394 usd
CY2023Q1 us-gaap Operating Expenses
OperatingExpenses
773850 usd
CY2024Q1 us-gaap Interest Expense
InterestExpense
53548 usd
CY2023Q1 us-gaap Interest Expense
InterestExpense
33875 usd
CY2024Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-53548 usd
CY2023Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-33875 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
-429942 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-807725 usd
CY2024Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.01
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.01
CY2024Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.01
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.01
CY2024Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
65072919 shares
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
61741326 shares
CY2024Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
65072919 shares
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
61741326 shares
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
-3005185 usd
CY2024Q1 GSLR Units Issued For Cash
UnitsIssuedForCash
80000 usd
CY2024Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
204590 usd
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
-3150537 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-2032238 usd
CY2023Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
498158 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-807725 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
-2341805 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
-429942 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-807725 usd
CY2024Q1 us-gaap Share Based Compensation
ShareBasedCompensation
204590 usd
CY2023Q1 us-gaap Share Based Compensation
ShareBasedCompensation
498158 usd
CY2024Q1 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-3279 usd
CY2023Q1 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-4040 usd
CY2024Q1 us-gaap Increase Decrease In Other Accounts Payable
IncreaseDecreaseInOtherAccountsPayable
-12183 usd
CY2023Q1 us-gaap Increase Decrease In Other Accounts Payable
IncreaseDecreaseInOtherAccountsPayable
76967 usd
CY2024Q1 GSLR Increase Decrease Accrued Compensation
IncreaseDecreaseAccruedCompensation
90000 usd
CY2023Q1 GSLR Increase Decrease Accrued Compensation
IncreaseDecreaseAccruedCompensation
45000 usd
CY2024Q1 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
46803 usd
CY2023Q1 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
154224 usd
CY2024Q1 GSLR Increase Decrease In Accrued Expenses Related Party
IncreaseDecreaseInAccruedExpensesRelatedParty
14955 usd
CY2023Q1 GSLR Increase Decrease In Accrued Expenses Related Party
IncreaseDecreaseInAccruedExpensesRelatedParty
0 usd
CY2024Q1 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
23584 usd
CY2023Q1 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
0 usd
CY2024Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-58914 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-29336 usd
CY2024Q1 us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
-0 usd
CY2023Q1 us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
1595 usd
CY2024Q1 us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
3569 usd
CY2023Q1 us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
3606 usd
CY2024Q1 us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
0 usd
CY2023Q1 us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
40000 usd
CY2024Q1 us-gaap Proceeds From Issuance Or Sale Of Equity
ProceedsFromIssuanceOrSaleOfEquity
80000 usd
CY2023Q1 us-gaap Proceeds From Issuance Or Sale Of Equity
ProceedsFromIssuanceOrSaleOfEquity
0 usd
CY2024Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
76431 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
34799 usd
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
17517 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
5463 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
5268 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
14320 usd
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
22785 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
19783 usd
CY2024Q1 us-gaap Interest Paid Net
InterestPaidNet
108 usd
CY2023Q1 us-gaap Interest Paid Net
InterestPaidNet
11652 usd
CY2024Q1 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
0 usd
CY2023Q1 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
0 usd
CY2024Q1 GSLR Expenses Paid On Companys Behalf
ExpensesPaidOnCompanysBehalf
0 usd
CY2023Q1 GSLR Expenses Paid On Companys Behalf
ExpensesPaidOnCompanysBehalf
1595 usd
CY2024Q1 us-gaap Use Of Estimates
UseOfEstimates
<p id="xdx_84D_eus-gaap--UseOfEstimates_zazOpGmParC9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i><span id="xdx_86C_zpSX64yHgK43">Use of Estimates</span></i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In preparing consolidated financial statements in conformity with accounting principles generally accepted in the United States of America, management is required to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes. Actual results could differ from those estimates in the accompanying consolidated financial statements involving the valuation of common stock and stock based compensation.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p>
CY2024Q1 us-gaap Convertible Long Term Notes Payable
ConvertibleLongTermNotesPayable
1235000 usd
CY2023Q4 us-gaap Convertible Long Term Notes Payable
ConvertibleLongTermNotesPayable
1235000 usd
CY2024Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000 shares
CY2024Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2024Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
20000000 shares
CY2024Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2024Q1 ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
CY2024Q1 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
CY2024Q1 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false
CY2024Q1 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false

Files In Submission

Name View Source Status
0001683168-24-003370-index-headers.html Edgar Link pending
0001683168-24-003370-index.html Edgar Link pending
0001683168-24-003370.txt Edgar Link pending
0001683168-24-003370-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
geosolar_ex3101.htm Edgar Link pending
geosolar_ex3102.htm Edgar Link pending
geosolar_ex3200.htm Edgar Link pending
geosolar_i10q-033124.htm Edgar Link pending
gslr-20240331.xsd Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
gslr-20240331_cal.xml Edgar Link unprocessable
gslr-20240331_def.xml Edgar Link unprocessable
gslr-20240331_lab.xml Edgar Link unprocessable
gslr-20240331_pre.xml Edgar Link unprocessable
geosolar_i10q-033124_htm.xml Edgar Link completed
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending